Heterogeneous distribution of P53 immunoreactivity in human lung adenocarcinoma correlates with MDM2 protein expression, rather than with p53 gene mutation

Medicine and Dentistry

• Protein P53 100%
• Protein P53 50%
• Lung Adenocarcinoma 27%
• Gene Mutation 16%
• Immunoreactivity 11%
• Exon 11%
• Tumor Suppressor Protein 11%
• Neoplasm 5%
• Inpatient 5%
• Polymerase Chain Reaction 5%
• Protein Expression 5%
• Cancer Tissue 5%
• Stroma 5%
• Indicator 5%
• Single Strand Conformation Polymorphism 5%
• Protein MDM2 5%

Biochemistry, Genetics and Molecular Biology

• P53 94%
• Gene Mutation 22%
• Mutation 16%
• Immunoreactivity 11%
• Exon 11%
• DNA 5%
• Genetics 5%
• Polymerase Chain Reaction 5%
• Protein Expression 5%
• Single-Strand Conformation Polymorphism 5%